SUZHOU, China and IRVINE, Calif., July 1, 2025 /PRNewswire/ — MedEdge Innovations (MEI), a leading developer of advanced medical materials and device technologies, today announced the official launch of its medical implant-grade expanded polytetrafluoroethylene (ePTFE) product line and comprehensive customized CDMO (Contract Development and Manufacturing Organization) services via a new digital platform: www.meimedtech.com.
This strategic expansion marks a major milestone in MEI’s ongoing mission to provide high-performance, customized medical solutions to device manufacturers worldwide.
Backed by more than a decade of innovation and engineering excellence, MEI leverages proprietary manufacturing processes and deep materials science expertise to deliver premium ePTFE components — including membranes, tubing, and ultra-thin tubing — tailored for cardiovascular, peripheral vascular, general surgery, and other life-saving applications.
“The launch of our ePTFE platform and CDMO services is a natural extension of MEI’s commitment to innovation, quality, and global collaboration,” said Tony Liu, CEO of MedEdge Innovations. “Through www.meimedtech.com, we are making our high-performance ePTFE materials more accessible to medical device innovators seeking reliability, scalability, and customization.”
Key Highlights of MEI’s ePTFE and CDMO Capabilities:
With the new platform, MEI aims to become a go-to partner for medical technology companies seeking biomaterials with superior durability, flexibility, and biocompatibility for both R&D and large-scale production.
To learn more about MEI’s ePTFE technologies and CDMO service offerings or to initiate a project consultation, visit www.meimedtech.com.
About MedEdge Innovations
MedEdge Innovations (MEI) is a forward-thinking medical technology company specializing in the development of advanced materials and devices that improve patient outcomes. With a strong foundation in proprietary platforms and R&D, MEI empowers next-generation medical innovation for global markets.
Website: www.meimedtech.com
SOURCE MEI Medical Technologies Co., Ltd.
Atropos Health is integrating the American Society of Clinical Oncology® (ASCO®) Guidelines into their platform…
PLANO, Texas, Dec. 5, 2025 /PRNewswire/ -- Teams playing in the StaffDNA® Cure Bowl were…
IRVINE, Calif., Dec. 5, 2025 /PRNewswire/ -- The Dot Corp has expanded its services with…
CHICAGO, Dec. 5, 2025 /PRNewswire/ -- Vaniam Group™, a category leader redefining medical communications, announced…
The Life Sciences BPO Market is expanding rapidly, driven by rising R&D costs, increasing regulatory…
Results confirm reproducibility and research readiness for islet isolation of Biorep's next generation laboratory platform.MIAMI,…